| 1 |
31920517 | Long Non-coding RNA KCNQ1OT1 Contributes to Antiepileptic Drug Resistance Through the miR-138-5p/ABCB1 Axis in vitro. | 2019 |
2 |
| 2 |
28748348 | Impact of Genetic Polymorphisms on Phenytoin Pharmacokinetics and Clinical Outcomes in the Middle East and North Africa Region. | 2017 Sep |
1 |
| 3 |
28875044 | Decreased Rivaroxaban Levels in a Patient with Cerebral Vein Thrombosis Receiving Phenytoin. | 2017 |
1 |
| 4 |
28961159 | In Vitro Assessment of the Effect of Antiepileptic Drugs on Expression and Function of ABC Transporters and Their Interactions with ABCC2. | 2017 Sep 29 |
1 |
| 5 |
26846610 | Reduced Anticoagulant Effect of Dabigatran in a Patient Receiving Concomitant Phenytoin. | 2016 Feb |
1 |
| 6 |
27450623 | Interactions between non-vitamin K oral anticoagulants and antiepileptic drugs. | 2016 Oct |
2 |
| 7 |
27602091 | Association between ABCB1 genetic polymorphism and the effect on epilepsy following phenytoin treatment. | 2016 Sep |
3 |
| 8 |
26228278 | Reversal of P-glycoprotein overexpression by Ginkgo biloba extract in the brains of pentylenetetrazole-kindled and phenytoin-treated mice. | 2015 Aug |
3 |
| 9 |
22641027 | Neurological toxicity after phenytoin infusion in a pediatric patient with epilepsy: influence of CYP2C9, CYP2C19 and ABCB1 genetic polymorphisms. | 2013 Aug |
1 |
| 10 |
23617068 | In silico exploration of phenytoin binding site in two catalytic states of human P-glycoprotein models. | 2013 Feb |
5 |
| 11 |
23658067 | Studies on pharmacokinetic mechanism of phenytoin resistance in refractory epilepsy. | 2013 Sep |
3 |
| 12 |
22239287 | Role of MDR1 C3435T and GABRG2 C588T gene polymorphisms in seizure occurrence and MDR1 effect on anti-epileptic drug (phenytoin) absorption. | 2012 Jun |
6 |
| 13 |
20417647 | In vitro concentration dependent transport of phenytoin and phenobarbital, but not ethosuximide, by human P-glycoprotein. | 2010 Jun 5 |
2 |
| 14 |
20417680 | Absence of a general association between ABCB1 genetic variants and response to antiepileptic drugs in epilepsy patients. | 2010 Sep |
1 |
| 15 |
19617466 | CYP2C9, CYP2C19, and ABCB1 genotype and hospitalization for phenytoin toxicity. | 2009 Dec |
1 |
| 16 |
19694743 | Gefitinib-phenytoin interaction is not correlated with the C-erythromycin breath test in healthy male volunteers. | 2009 Aug |
5 |
| 17 |
18824002 | Several major antiepileptic drugs are substrates for human P-glycoprotein. | 2008 Dec |
1 |
| 18 |
17376120 | Intestinal expression of cytochrome P450 enzymes and ABC transporters and carbamazepine and phenytoin disposition. | 2007 Apr |
2 |
| 19 |
17529887 | Therapeutic drug monitoring and clinical outcomes in epileptic Egyptian patients: a gene polymorphism perspective study. | 2007 Jun |
2 |
| 20 |
17910594 | ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy. | 2007 |
1 |
| 21 |
16220110 | CYP2C9, CYP2C19, ABCB1 (MDR1) genetic polymorphisms and phenytoin metabolism in a Black Beninese population. | 2005 Nov |
5 |
| 22 |
12954800 | Interaction of antiepileptic drugs with human P-glycoprotein in vitro. | 2003 Oct |
1 |
| 23 |
11908757 | The predictive value of MDR1, CYP2C9, and CYP2C19 polymorphisms for phenytoin plasma levels. | 2001 |
12 |
| 24 |
8001500 | MDR1 gene expression in brain of patients with medically intractable epilepsy. | 1995 Jan |
2 |